Log In
Print this Print this

PB1023 (formerly Glymera)

  Manage Alerts
Collapse Summary General Information
Company PhaseBio Pharmaceuticals Inc.
DescriptionRecombinant glucagon-like peptide-1 (GLP-1) analog
Molecular Target Glucagon-like peptide-1 (GLP-1)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today